Clinical Research
corporate_fare

Navigator Medicines Inc.

Address
2525 Smith Street

Sponsor Overview

assignment
1
sponsored trial
science
2
molecules
location_city
22
research centres
public
5
countries
person_search
24
investigators

Specializations

Hidradenitis Suppurativa

Navigator Medicines Inc. focuses on moderate-to-severe hidradenitis suppurativa, a chronic inflammatory skin condition marked by recurrent painful lesions and persistent disease burden.

  • Inflammatory skin disease
  • Moderate-to-severe hidradenitis suppurativa
  • Adult patient population

The sponsor’s clinical activity centers on therapeutic options intended for adults living with ongoing hidradenitis suppurativa.

Dermatology

The clinical research portfolio is situated within dermatology, with attention to conditions that affect the skin, hair follicles, and surrounding tissue.

  • Skin inflammation
  • Chronic dermatologic disorders
  • Lesion-associated disease

Research interests in this area are aligned with treatment development for difficult-to-manage cutaneous inflammatory disease.

Immuno-Inflammatory Disease

Navigator Medicines Inc. is engaged in research for immune-mediated inflammatory conditions that involve persistent tissue inflammation and symptom recurrence.

  • Immune-driven inflammation
  • Chronic inflammatory disorders
  • Therapeutic modulation of inflammation

This area reflects a focus on conditions where controlling inflammatory activity is central to treatment.

Adult Therapeutics

The sponsor’s trial activity is directed toward adult participants, indicating an interest in therapies tailored to the needs of mature patient populations.

  • Adult treatment populations
  • Symptom burden management
  • Long-term disease control

Clinical interest is concentrated on treatment approaches relevant to adults with ongoing chronic skin disease.

Sponsored Trials

Trial Name Country Status
A Phase 2a, Randomized, Double-blind, Placebo-controlled Study to Evaluate the Efficacy and Safety of NAV-240 in Adults with Moderate-to-Severe Hidradenitis SuppurativaBulgaria BulgariaGermany GermanyHungary HungaryPoland PolandRomania RomaniaRecruiting

Data & Insights

science
Molecule Portfolio
Compounds under investigation
1
Exclusive Molecules
out of 2 total (50% not shared with other sponsors)

This sponsor works with 2 molecules, of which 1 is not being studied by other sponsors.

hub
Site Partnerships
Collaboration with research centres
0%
Return partnership rate
0 of 22 sites collaborated multiple times

This sponsor has worked with 22 sites across their trial portfolio.

Therapeutic Focus

  • 1.
    Skin and Connective Tissue Diseases1 trial
    247 other sponsors

Partnered Research Centres

22 centres
location_city
assignment31
ASMC – IPSMC - Skin And Venereal Diseases
Address
Ulitsa Persenk 19, Enter B Floor 1 App 13, 1407 Sofia
Learn morearrow_forward
location_city
assignment518
Center For Pediatric And Adolescent Medicine Of The Johannes Gutenberg University Mainz
Address
Langenbeckstrasse 1, Oberstadt, 55131 Mainz
Learn morearrow_forward
location_city
assignment29
Centrum Zdrowia Dziecka I Rodziny Im. Jana Pawla II W Sosnowcu Sp. z o.o.
Address
Ul. Gabrieli Zapolskiej 3, 41-218 Sosnowiec
Learn morearrow_forward
location_city
assignment1047
Charite Universitaetsmedizin Berlin KöR
Address
Hindenburgdamm 30, Lichterfelde, 12203 Berlin
Learn morearrow_forward
location_city
assignment25
Dermatologie Quist
Address
Haifa-Allee 20, 55128 Mainz
Learn morearrow_forward
location_city
assignment5
Dermedic Jacek Zdybski
Address
ul. Klonowa 107/L7, 25-553 Kielce
Learn morearrow_forward
Page 1 of 4

Want to get in touch with this sponsor?

Send a question and we'll pass it on to Navigator Medicines Inc..

Need a custom report on this sponsor?

Competitive positioning, market entry, partnership opportunities — tell us the question.

Is something out of date?

Tell us what needs correcting and we'll update this profile.